Sign in

CIK 0001018735 · Accelerated filer

NYMOX PHARMACEUTICAL CORP

Sign in to watch
Ticker
NYMXF
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Entity type
other
Phone
1-800-936-9669
Business address
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. UPLOAD Other SEC-generated Letter
  4. F-3 Offering F-3
  5. 6-K/A Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 20-F/A Report Annual and Transition Report of Foreign Private Issuers
  10. EFFECT Other Notice of Effectiveness
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. 6-K Event Report of Foreign Issuer
  13. UPLOAD Other SEC-generated Letter
  14. F-3 Offering F-3
  15. 6-K Event Report of Foreign Issuer
  16. 4 Insider Changes in Ownership
  17. 20-F Report Annual and Transition Report of Foreign Private Issuers
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. 6-K Event Report of Foreign Issuer

Page 4 of 21 · 408 filings